Gallant Revenue and Competitors

Location

$11M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Gallant's estimated annual revenue is currently $1.8M per year.(i)
  • Gallant's estimated revenue per employee is $77,500
  • Gallant's total funding is $11M.

Employee Data

  • Gallant has 23 Employees.(i)
  • Gallant grew their employee count by 15% last year.

Gallant's People

NameTitleEmail/Phone
1
Founder & CEOReveal Email/Phone
2
President & Chief Scientific OfficerReveal Email/Phone
3
Scientific AdvisorReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$32.9M2308%$5MN/A
#2
$1.8M2315%$11MN/A
#3
$16M7151%N/AN/A
#4
$2791.7M81393%N/AN/A
Add Company

What Is Gallant?

Gallant is a new and unique regenerative medicine business focusing on helping pets have better, higher-quality lives. Partnering with veterinarians and pet parents, Gallant has the ability to collect and bank young stem cells from the reproductive tissue which would otherwise be discarded during a spay/neuter. These young, potent stem cells are stored for the future when distinct therapies are needed. Gallant opens a new world of wellness opportunity and makes proven regenerative medicine accessible to pets, pet parents and veterinarians.

keywords:N/A

$11M

Total Funding

23

Number of Employees

$1.8M

Revenue (est)

15%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Gallant News

2022-04-20 - Canada's Peterman, Gallant meet early exit from mixed doubles worlds with loss to Norway

Canada's Jocelyn Peterman and Brett Gallant were knocked out of the world mixed doubles curling championship in Geneva on Friday after...

2022-04-20 - Canada's Peterman and Gallant fall short of podium at world ...

Brett Gallant and Jocelyn Peterman compete at the World Mixed Doubles Curling Championship 2022, Geneva, Switzerland on Friday, April 29, 2022.

2022-04-17 - P.E.I.'s Gallant loses in world mixed doubles qualification game

Brett Gallant and Jocelyn Peterman represented Canada at the 2022 world mixed doubles curling championship in Geneva, Switzerland. STORY...

2019-10-24 - Newly launched pet health startup Gallant wants you to bank your dog’s stem cells for $990

With $11 million in funding and a mission to open up the doors of regenerative therapies to dogs across the nation, the Los Angeles-based startup Gallant is now opening its doors for the first time. The company was founded by DogVacay founder and chief executive Aaron Hirschhorn after seeing hi ...

2019-10-24 - Gallant Raises $11M in Funding

Gallant, a Los Angeles, CA-based animal biotech company, raised $11m in funding. Backers included Maveron, Bold Capital Partners, Bling Capital, Science Inc. and more. The company is using the funds for research and development, clinical studies to advance treatments and education campaigns on ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$4.3M23-8%N/A
#2
$3.4M2321%N/A
#3
$2.3M23N/AN/A
#4
$4M23-21%$74.4M
#5
$2.4M235%N/A